CMG Pharmaceutical Co Ltd
KOSDAQ:058820
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
CMG Pharmaceutical Co Ltd
Cash from Financing Activities
CMG Pharmaceutical Co Ltd
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
CMG Pharmaceutical Co Ltd
KOSDAQ:058820
|
Cash from Financing Activities
₩945.8m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Cash from Financing Activities
₩8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-18%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Cash from Financing Activities
-₩156.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Cash from Financing Activities
-₩97.2B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Cash from Financing Activities
₩22.8B
|
CAGR 3-Years
20%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Cash from Financing Activities
-₩31.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
CMG Pharmaceutical Co Ltd
Glance View
CMG Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical drugs. The company is headquartered in Seoul, Seoul and currently employs 243 full-time employees. The company went IPO on 2001-08-31. The Company’s products include antibiotics, antifungals, antivirus, anti-tuberculousis drugs, peptic ulcer drugs, dementia remedies, antihistamines and antipyretics, among others. The company is also engaged in the manufacture of stone products. The firm mainly distributes is pharmaceutical products within domestic markets, as well as to overseas markets. On April 16, 2013, the Company changed its name from SKYNEWPHARM. Co., Ltd to CMG Pharmaceutical Co., Ltd.
See Also
What is CMG Pharmaceutical Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
945.8m
KRW
Based on the financial report for Dec 31, 2025, CMG Pharmaceutical Co Ltd's Cash from Financing Activities amounts to 945.8m KRW.
What is CMG Pharmaceutical Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-45%
Over the last year, the Cash from Financing Activities growth was -98%. The average annual Cash from Financing Activities growth rates for CMG Pharmaceutical Co Ltd have been -45% over the past three years .
